Sagimet Biosciences Inc. - Series ASagimet Biosciences Inc. - Series ASagimet Biosciences Inc. - Series A

Sagimet Biosciences Inc. - Series A

No trades
See on Supercharts

Price target

29.170.000.00%
The 6 analysts offering 1 year price forecasts for SGMT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to SGMT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SGMT EPS for the last quarter is −0.45 USD despite the estimation of −0.39 USD. In the next quarter EPS is expected to reach −0.56 USD. Track more of Sagimet Biosciences Inc. - Series A financials and stay on top of what is up with the company.
In the next quarter Sagimet Biosciences Inc. - Series A revenue is expected to reach 0.00 USD. Check out Sagimet Biosciences Inc. - Series A revenue and earnings and make informed decisions.
According to analysts, SGMT price target is 29.17 USD with a max estimate of 67.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Sagimet Biosciences Inc. - Series A stock price chart and keep track of the current situation with SGMT news and stock market news.
We've gathered opinions of 7 analysts rating SGMT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.